We research genetic questions to help you make important decisions about your health.
MiraKind conducts cutting-edge research on a new class of genetic markers that provides powerful information about personalized disease risk, treatment, and management.
What We Do
MiraKind conducts patient-centric research to better understand novel inherited gene mutations, such as the KRAS-variant, to help:
“It’s wonderful to feel that my participation in a study may have such meaning for others. I am so grateful my daughter, my daughter-in-law, and all young women will benefit from your efforts. For the first time since my diagnosis, I felt more powerful than my cancer.”
FROM THE DECEMBER 2014 ISSUE
Despite the dangers of the KRAS-variant mutation, few doctors have heard of it. But one researcher is trying to change that.